(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.06%62.27B | 0.26%39.38B | 4.88%19.18B | -0.33%82.55B | 2.44%59.84B | 7.25%39.28B | 6.47%18.29B | 2.66%82.82B | -1.22%58.42B | -0.66%36.62B |
Operating income | 4.06%62.27B | 0.26%39.38B | 4.88%19.18B | -0.33%82.55B | 2.44%59.84B | 7.25%39.28B | 6.47%18.29B | 2.66%82.82B | -1.22%58.42B | -0.66%36.62B |
Operating expenses | -9.71%-39.4B | -7.51%-24.19B | -8.37%-11.65B | 4.38%-52.86B | 1.93%-35.92B | -2.53%-22.5B | -4.78%-10.75B | -2.57%-55.28B | 3.20%-36.62B | 5.29%-21.95B |
Gross profit | -4.43%22.87B | -9.47%15.19B | -0.09%7.53B | 7.80%29.69B | 9.79%23.93B | 14.31%16.77B | 8.97%7.54B | 2.83%27.54B | 2.31%21.79B | 7.18%14.67B |
Selling expenses | 15.62%-30.67M | 14.30%-17.32M | -7.01%-9.05M | 13.29%-41.06M | -20.60%-36.35M | 4.25%-20.22M | -1.21%-8.46M | 40.06%-47.35M | 48.61%-30.14M | 54.11%-21.11M |
Administrative expenses | 2.02%-1.78B | 0.20%-1.15B | 0.04%-557.66M | -10.09%-2.66B | -2.14%-1.81B | 1.98%-1.15B | 2.06%-557.89M | 0.26%-2.42B | -8.79%-1.78B | -6.20%-1.18B |
Research and development expenses | 14.99%-887.16M | 53.92%-312.23M | 46.13%-113.17M | -29.41%-2.42B | -17.82%-1.04B | -51.22%-677.53M | -57.41%-210.07M | -6.66%-1.87B | -20.29%-885.73M | 14.04%-448.03M |
Profit from asset sales | 269.17%11.14M | 135.85%7.12M | -99.87%4.02K | -37.49%3.89M | -45.99%3.02M | 39.63%3.02M | 67.59%3.11M | 7,817.98%6.23M | 7,681.74%5.59M | --2.16M |
Revaluation surplus | ---- | 88.52%-549.92K | ---- | -117.36%-9.64M | -105.26%-4.57M | -108.17%-4.79M | ---- | 153.80%55.55M | 245.85%86.82M | 715.17%58.62M |
-Changes in the fair value of other assets | ---- | 88.52%-549.92K | ---- | -117.36%-9.64M | -105.26%-4.57M | -108.17%-4.79M | ---- | 153.80%55.55M | 245.85%86.82M | 715.17%58.62M |
Impairment and provision | 345.32%145.96M | 336.11%141.62M | 71,031.41%138.52M | -121.15%-334.46M | -23.39%-59.5M | -26.20%-59.98M | -61.53%194.74K | 7.04%-151.24M | -3,004.20%-48.22M | -3,389.77%-47.53M |
-Other impairment is provision | 345.32%145.96M | 336.11%141.62M | 71,031.41%138.52M | -121.15%-334.46M | -23.39%-59.5M | -26.20%-59.98M | -61.53%194.74K | 7.04%-151.24M | -3,004.20%-48.22M | -3,389.77%-47.53M |
Special items of operating profit | 21.04%2.84B | 24.73%2.08B | -13.48%806.89M | -7.00%2.91B | -0.77%2.35B | 37.94%1.67B | 36.66%932.57M | 0.74%3.13B | -8.60%2.37B | -16.17%1.21B |
Operating profit | -0.82%22.51B | -3.77%15.49B | 1.23%7.6B | 3.23%26.26B | 8.42%22.7B | 16.02%16.1B | 11.53%7.51B | 2.76%25.44B | -0.21%20.93B | 5.70%13.88B |
Financing cost | 8.22%-3.88B | 15.25%-2.5B | 1.73%-1.27B | 14.05%-5.67B | 15.76%-4.23B | 9.40%-2.95B | 17.12%-1.29B | -2.98%-6.59B | -1.22%-5.02B | 0.19%-3.26B |
Special items of earning before tax | 60.82%-29.36M | 60.85%-30.29M | 132.69%7.65M | 56.04%-63.93M | -57.53%-74.95M | -371.80%-77.36M | -295.14%-23.39M | 22.45%-145.44M | -1,037.79%-47.58M | -81.44%-16.4M |
Earning before tax | 1.12%18.6B | -0.84%12.96B | 2.35%6.34B | 9.79%20.53B | 15.93%18.39B | 23.28%13.07B | 19.85%6.2B | 2.94%18.7B | -0.92%15.87B | 7.58%10.6B |
Tax | -0.50%-3.1B | 2.26%-2.11B | -1.12%-982.23M | -0.76%-3.48B | -11.30%-3.09B | -23.28%-2.16B | -7.20%-971.35M | -41.62%-3.46B | -30.00%-2.77B | -47.87%-1.75B |
After-tax profit from continuing operations | 1.25%15.5B | -0.55%10.85B | 2.58%5.36B | 11.84%17.05B | 16.91%15.31B | 23.28%10.91B | 22.53%5.22B | -3.07%15.24B | -5.67%13.09B | 2.07%8.85B |
Earning after tax | 1.25%15.5B | -0.55%10.85B | 2.58%5.36B | 11.84%17.05B | 16.91%15.31B | 23.28%10.91B | 22.53%5.22B | -3.07%15.24B | -5.67%13.09B | 2.07%8.85B |
Minority profit | -1.66%5.51B | -5.34%3.74B | 0.96%1.75B | 19.77%6.32B | 30.29%5.61B | 34.03%3.95B | 23.10%1.74B | -11.44%5.28B | -16.76%4.3B | -7.08%2.95B |
Profit attributable to shareholders | 2.93%9.98B | 2.16%7.11B | 3.38%3.6B | 7.64%10.72B | 10.36%9.7B | 17.91%6.96B | 22.25%3.49B | 2.04%9.96B | 0.90%8.79B | 7.34%5.9B |
Basic earnings per share | 2.92%0.1977 | 2.17%0.141 | 2.90%0.071 | 7.61%0.212 | 10.34%0.1921 | 17.95%0.138 | 23.21%0.069 | 2.07%0.197 | 0.93%0.1741 | 7.34%0.117 |
Diluted earnings per share | 2.92%0.1977 | 2.17%0.141 | 2.90%0.071 | 7.61%0.212 | 10.34%0.1921 | 17.95%0.138 | 23.21%0.069 | 2.07%0.197 | 0.93%0.1741 | 7.34%0.117 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data